Author name: TB Alliance

The Global Alliance for TB Drug Development has no medical labs, which might seem a odd for a group that

Chiron Corp. signed an innovative deal last week that could set a pattern for how corporations and nonprofits can work

The Global Alliance for TB Drug Development is holding up its new deal with Chiron Corp. as one example of

The US-based Global Alliance for TB Drug Development, a one-year old private and public venture participation company has announced that

In one of the first drug development deals between a drug maker and a nonprofit organization, the Global Alliance for

EMERYVILLE, Calif. — In one of the first drug-development deals between a drug maker and a nonprofit organization, the Global

On Friday, Chiron Corp. announced it had agreed to license rights for an experimental compound to a nonprofit group dedicated

Emeryville, California, Feb. 1 (Bloomberg) — Chiron Corp. agreed to license rights for an experimental compound to a non-profit group

Multinational pharmaceutical companies and research institutions are racing to meet a 2010 target for developing a new drug to fight